Subtype-selective sodium channel blockers promise a new era of pain research
- PMID: 17488822
- PMCID: PMC1895929
- DOI: 10.1073/pnas.0703091104
Subtype-selective sodium channel blockers promise a new era of pain research
Conflict of interest statement
Conflict of interest statement: B.T.P. and G.J.K. are employees of Merck & Co., Inc., and own stock and hold stock options in the company.
Figures
Comment on
-
A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.Proc Natl Acad Sci U S A. 2007 May 15;104(20):8520-5. doi: 10.1073/pnas.0611364104. Epub 2007 May 2. Proc Natl Acad Sci U S A. 2007. PMID: 17483457 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
